W06.1- Impact of Elexacaftor/Tezacaftor/Ivacaftor therapy on gastrointestinal inflammation, motility, and symptoms in Cystic Fibrosis: A multicenter prospective study

Thursday, October 23, 2025

10:15 AM - 12:15 PM PDT

Location: Signature Room

Speaker(s)

LB

Liron Birimberg-Schwartz, n/a

Hadassah Medical Center and the Faculty of Medicine